Citation: S. Verenich et al., Combination of coagulation and catalytic wet oxidation for the treatment of pulp and paper mill effluents, WATER SCI T, 44(5), 2001, pp. 145-152
Authors:
Ablamunits, V
Bridgett, M
Duffy, T
Haag, F
Nissen, M
Koch-Nolte, F
Leiter, H
Citation: V. Ablamunits et al., Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice, DIABETOLOG, 44(7), 2001, pp. 848-858
Authors:
Kahl, S
Nissen, M
Girisch, R
Duffy, T
Leiter, EH
Haag, F
Koch-Nolte, F
Citation: S. Kahl et al., Metalloprotease-mediated shedding of enzymatically active mouse ecto-ADP-ribosyltransferase ART2.2 upon T cell activation, J IMMUNOL, 165(8), 2000, pp. 4463-4469
Authors:
Himes, SR
Reeves, R
Attema, J
Nissen, M
Li, Y
Shannon, MF
Citation: Sr. Himes et al., The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation, J IMMUNOL, 164(6), 2000, pp. 3157-3168
Citation: M. Nissen et al., Integrated analysis and design of knowledge systems and processes, KNOWLEDGE MANAGEMENT AND VIRTUAL ORGANIZATIONS, 2000, pp. 214-244
Citation: M. Nissen et al., Unscientific psychology: A cultural-performatory approach to understandinghuman life., THEOR PSYCH, 9(3), 1999, pp. 417-426
Authors:
Braren, R
Glowacki, G
Nissen, M
Haag, F
Koch-Nolte, F
Citation: R. Braren et al., Molecular characterization and expression of the gene for mouse NAD(+): arginine ecto-mono(ADP-ribosyl)transferase, Art1 (vol 336, pg 561, 1998), BIOCHEM J, 341, 1999, pp. 862-862
Authors:
Gerwien, J
Nielsen, M
Labuda, T
Nissen, M
Svejgaard, A
Geisler, C
Ropke, C
Odum, N
Citation: J. Gerwien et al., Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells, J IMMUNOL, 163(4), 1999, pp. 1742-1745
Authors:
Koch-Nolte, F
Duffy, T
Nissen, M
Kahl, S
Killeen, N
Ablamunits, V
Haag, F
Leiter, EH
Citation: F. Koch-nolte et al., A new monoclonal antibody detects a developmentally regulated mouse ecto-ADP-ribosyltransferase on T cells: Subset distribution, inbred strain variation, and modulation upon T cell activation, J IMMUNOL, 163(11), 1999, pp. 6014-6022
Authors:
Ebeling, P
Teppo, AM
Koistinen, HA
Viikari, J
Ronnemaa, T
Nissen, M
Bergkulla, S
Salmela, P
Saltevo, J
Koivisto, VA
Citation: P. Ebeling et al., Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes, DIABETOLOG, 42(12), 1999, pp. 1433-1438
Authors:
Tuomi, T
Carlsson, A
Li, HY
Isomaa, B
Miettinen, A
Nilsson, A
Nissen, M
Ehrnstrom, BO
Forsen, B
Snickars, B
Lahti, K
Forsblom, C
Saloranta, C
Taskinen, MR
Groop, LC
Citation: T. Tuomi et al., Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies, DIABETES, 48(1), 1999, pp. 150-157
Authors:
Braren, R
Glowacki, G
Nissen, M
Haag, F
Koch-Nolte, F
Citation: R. Braren et al., Molecular characterization and expression of the gene for mouse NAD(+): arginine ecto-mono(ADP-ribosyl)transferase, Art1, BIOCHEM J, 336, 1998, pp. 561-568